Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza A polymerase basic protein 2 (PB2) is a subunit of the viral RNA-dependent RNA polymerase complex. It is essential for viral transcription and replication. PB2 recognizes and binds to the 5' cap structures of host pre-mRNAs, initiating viral mRNA synthesis through a process called "cap-snatching". Residue K627 is a key determinant of host range and pathogenicity. Some variants can localize to mitochondria and interact with MAVS, potentially modulating immune responses.
Inhibition of cap-snatching, Inhibition of polymerase complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza A Polymerase Basic Protein 2 (PB2).